DAY 1 – Friday, 20 October 2017
Welcome and Introduction to EndoBridge 2017
The Pituitary hepatic pancreatic axis
–
AJ van der Lely
Aggressive pituitary tumors
–
Gerald Raverot
Medical management in Cushing’s disease
–
Lynnette Nieman
Hyponatremia - When and how should be treated?
–
Chris J. Thompson
Secondary amenorrhea: From hypothalamus to ovary
- George Mastorakos
Increasing complexity and challenges in male hypogonadism
- Dimitrios Goulis
DAY 2 – Saturday, 21 October 2017
Cardiovascular outcomes of antidiabetic medications
- Leszek Czupryniak
Management of hyperglycemia in the hospitalized patient
- Priyathama Vellanki
New insulin and GLP-1 combinations in diabetes
- Sten Madsbad
Difficult cases in primary hyperparathyroidism
- Aliya Khan
Monogenic bone diseases as models for osteoporosis treatment
- Jens Bollerslev
What is new in osteoporosis treatment?
- Misa Pfeifer
DAY 3 – Sunday, 22 October 2017
Update of thyroid disorders in pregnancy
- Marco Medici
What is new in the diagnosis and management of Graves' hyperthyroidism?
- Tomasz Bednarczuk
New terminology in thyroid cancer
- Isabel Amendoeira
Response and toxicity of tyrosine kinase inhibitors
- Katerina Saltiki
Microbiota and metabolic disorders
- Okan Bülent Yýldýz
Reversal of Type 2 diabetes through lifestyle, pharmacotherapy and bariatric surgery
- Barbara McGowan
Endocrine and metabolic complications in post-bariatric surgery patients
- Karl Neff
